Cofactor Genomics: Funding, Investors & Team (Sep 2026)
Cofactor Genomics is a company that specializes in predictive immune modeling. Their goal is to enhance precision medicine by overcoming current obstacles. Cofactor aims to replace single-analyte biomarkers with more comprehensive multidimensional biomarkers using health expression models. They have expertise in molecular biology, informatics, and database management, and offer molecular, informatic, and database tools. They also have one of the first CAP-certified clinical RNA sequencing laboratories, which helps their partners carry out clinical trials more effectively and at a lower cost. Through their services, Cofactor contributes to medical research and improves patient outcomes in the healthcare and pharmaceutical sectors.
Cofactor Genomics has raised $8.1M across 3 funding rounds on record, the most recent an undisclosed round announced in Dec 2025.
Cofactor Genomics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Cofactor Genomics Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Cofactor Genomics raised $6.9M in an undisclosed round announced in Dec 2021.
1.7 years later, an undisclosed round of $1.2M was announced in Aug 2023.
2.3 years later, an undisclosed round was announced in Dec 2025 with no disclosed amount.
Cofactor Genomics Founders and Leadership Team
Contact details for the Cofactor Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →Cofactor Genomics Funding Compared to Other Biotechnology Startups
Funded Startups Like Cofactor Genomics in Biotechnology and San Francisco
Companies Similar to Cofactor Genomics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Cofactor Genomics Funding FAQs
What does Cofactor Genomics do?
Cofactor Genomics is a company that specializes in predictive immune modeling. Their goal is to enhance precision medicine by overcoming current obstacles. Cofactor aims to replace single-analyte biomarkers with more comprehensive multidimensional biomarkers using health expression models. They have expertise in molecular biology, informatics, and database management, and offer molecular, informatic, and database tools. They also have one of the first CAP-certified clinical RNA sequencing laboratories, which helps their partners carry out clinical trials more effectively and at a lower cost. Through their services, Cofactor contributes to medical research and improves patient outcomes in the healthcare and pharmaceutical sectors.
How much funding has Cofactor Genomics raised?
Cofactor Genomics has raised $8.1M across 3 rounds on record.
When did Cofactor Genomics last raise funding?
Cofactor Genomics' most recent funding round on record was announced in Dec 2025. The amount was not disclosed.
Who is the CEO of Cofactor Genomics?
Jarret Glasscock is listed as CEO at Cofactor Genomics.
Where is Cofactor Genomics headquartered?
Cofactor Genomics is based in San Francisco, California, United States.
How many employees does Cofactor Genomics have?
Cofactor Genomics is in the 11-50 employee band.
About FundedIQ's Cofactor Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cofactor Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.